Université catholique de Louvain, Louvain Drug Research Institute, Metabolism and Nutrition Research Group, PMNT Unit, Brussels, Belgium.
Curr Opin Pharmacol. 2009 Dec;9(6):737-43. doi: 10.1016/j.coph.2009.06.016. Epub 2009 Jul 21.
Obesity and associated metabolic disorders are worldwide epidemic. The literature provides new evidence that gut microbiota dysbiosis (at the phyla, genus, or species level) affects host metabolism and energy storage. Here we discuss new findings that may explain how gut microbiota can be involved in the development or in the control of obesity and associated low-grade inflammation. New powerful molecular biology methods and the use of gnotobiotic animal allowed to analyze the molecular link between gut bacteria and the host. Moreover, even if more studies are needed to unravel how changing gut microbiota impacts on the development of obesity and related metabolic alterations, probiotic and prebiotic approach appear as potential interesting treatments to reverse host metabolic alterations linked to gut microbiota dysbiosis.
肥胖症和相关代谢紊乱是全球性的流行病。文献提供了新的证据表明,肠道微生物群落失调(在门、属或种水平上)会影响宿主的代谢和能量储存。在这里,我们讨论了新的发现,这些发现可能解释了肠道微生物群如何参与肥胖症和相关低度炎症的发展或控制。新的强大的分子生物学方法和无菌动物的使用允许分析肠道细菌和宿主之间的分子联系。此外,尽管还需要更多的研究来阐明肠道微生物菌群的变化如何影响肥胖症的发展和相关代谢改变,但益生菌和益生元的方法似乎是一种潜在的有趣的治疗方法,可以逆转与肠道微生物群落失调相关的宿主代谢改变。